Search results for " 2020"
Article
CDMOs Driving Emerging Bio/Pharma Success
Many economists see the likelihood of a recession in the United States in 2019 or 2020; the Trump administration campaigned on the promise to bring down drug prices; and US corporations look to be get…
Article
Witnessing Major Growth in Next-Generation Antibodies
Including next-gen antibodies in pharma pipelines is considered essential for future success.
By Cynthia A. Challener
Next-generation antibodies are designed to be more specific and are ofte…
Article
Optimizing Cation-Exchange Chromatography with High-Throughput Process Development for mAb Purification
A study by BioProcess Technology Consultants estimated that approximately 70 mAb products could be on the market by 2020, which could be associated with up to £125 billion in sales (1).
Purifying …
Article
Drug Discovery and Development in India
Government initiatives
According to Pachhapur, the government has taken many initiatives in accordance with India’s Department of Pharmaceuticals Pharma Vision 2020 (7), which is designed to make …
Article
The Bullish Outlook for Biosimilars
Feb 01, 2015
By Jill E. Sackman, PhD, Michael J. Kuchenreuther, PhD
BioPharm International
There are several important reasons for stakeholders to be optimistic about prospects for b…
Article
Setting Standards for Biotech Therapeutics in India
The authors take a look at the past and future impact of the Indian Pharmacopoeia Commission.
By: Anurag S. Rathore, PhD, Renu Jain, M. Kalaivani, Gunjan Narula, G. N. Singh
BioPharm Inter…
Article
Pharma Investments Reflect Key Industry Trends
The company will spend nearly $694 million at existing sites in Leverkusen and Wuppertal, Germany to expand production of its hemophilia drug Kogenate (antihemophilic factor), adding 500 workers by 20…
Article
Global Expansion Shapes Drug Oversight
These activities will be on the agenda at the next USP convention in April 2015, which will set the stage for USP programs through 2020, when the organization marks its 200th anniversary. To prepare f…
Article
Monoclonal Antibodies Key to Unlocking the Biosimilars Market
mAbs comprise a much larger class, and by 2020, patents are set to expire on several mAb-based drugs with annual sales greater than $5 billion each in the year of US expiry,” says Jorge Santos da Silv…
Article
Early Communication with Regulators is Essential for SMEs
SMEs on the rise
The European Union is currently calling SMEs “the powerhouse” of its Innovation Union, a concept behind its new seven-year €77 billion research program called Horizon 2020, which…